Ungated Post | 01 Sep 2020
Accenture 2020 Digital Health Consumer Survey: How can leaders make recent digital health gains last?
The global pandemic greatly accelerated the adoption of digital healthcare—but will it persist?
Oxford Economics worked with Accenture to survey 7,800 consumers in seven countries about their attitudes toward and adoption of virtual healthcare. Following the onset of the COVID-19 pandemic, we revisited the data to understand how providers, payers, and consumers can maintain the momentum created by forced adoption of virtual services, and address the pre-crisis issues—like privacy, security, and trust—that have previously inhibited digital health adoption.
View the results by country:
Australia
England
Finland
Norway
Singapore
Spain
United States
Our Thought Leadership team produces original, evidence-based research made accessible to decision-makers and opinion leaders. Principals for this project included:
Oxford Economics’ team is expert at applying advanced economic tools that provide valuable insights into today’s most pressing business, financial, and policy issues.
To find out more about our capabilities, contact:
EMEA
Paul Donnelly
020 3910 8000
Email
Americas
Diantha Redd
+1 (646) 503 3052
Email
Asia
Christie Tang
+852 3974 8841
Email
Related Services
Post
German Fashion Footprint
This report, following on Oxford Economics' work that estimated the econoimc impact of the German fashion industry, looks at the global environmental footprint that the industry has in terms of emissions, polliution and resource usage.
Find Out More
Post
Experian / Oxford Economics Main Street Report
Experian/Oxford Economics’ Main Street Report brings deep insight into the overall financial well-being of the small-business landscape, as well as provides commentary on what specific trends mean for credit grantors and the small-business community.
Find Out More
Post
The Economics of Reduced-Risk Products: Global policy landscape and principles for policy treatment
In this study, Oxford Economics assesses the policy landscape for ‘Reduced-Risk Products’ in the tobacco market, and explores the potential health and economics consequences of taking a precautionary policy stance against them.
Find Out More